Fate Therapeutics (FATE)
Nasdaq • FATE • US31189P1021
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 8.9% of free float sold short, 7.4 days to cover, cost to borrow 0.6%. Sign up for live short interest data.
Market Cap
212m USD | # 7386 in US
Volume
1.43m shares | 3.28m USD
Shares Outstanding
119.82m
Free Float Shares
88.25% | 105.74m
